Gross Profit, Operating Income, and Net Income as a percentage of Revenue

Gross Margin

Operating Margin

Profit Margin

Margins

An operating expense is an expense a business incurs through its normal business operations. Often abbreviated as OPEX.

Selling, general and administrative

Equity earnings (loss) in AmerisourceBergen

Impairment of goodwill

Operating Expenses

Year over year growth in Revenue and Operating Expenses.

Revenue Y/Y

OpEx Y/Y

Growth

Shares outstanding refer to a company's stock currently held by all its shareholders, including share blocks held by institutional investors and restricted shares owned by the company's officers and insiders.

Outstanding Shares

Market Cap

Also known as Price/Sales Ratio. Calculated using Average market cap for the quarter / Annualized quarterly revenue.

Revenue Multiple

Walgreens

Duane Reade is a subsidiary of Walgreens Boots Alliance, is a chain of pharmacy and convenience stores, primarily located in New York City, known for its high volume small store layouts in densely populated Manhattan locations.

Duane Reade

Boots UK is a pharmacy chain in the United Kingdom, Ireland, Norway, Thailand and other territories. Boots became a subsidiary of the new company, Walgreens Boots Alliance, on 31 December 2014.

Boots UK

Alliance Healthcare was formerly Alliance UniChem, wholesales, distributes, and retails pharmaceutical, surgical, medical, and healthcare products throughout Europe. The company supplies more than 110,000 pharmacies, doctors, health centres and hospitals from over 288 distribution centres in 11 countries. The company is a wholly owned subsidiary of Walgreens Boots Alliance, which was formed by the merger of Walgreens with its former parent Alliance Boots in 2014. Alliance Boots had itself been formed in 2006 by the merger of Boots Group and Alliance UniChem on 31 July 2006. Alliance UniChem was rebranded Alliance Healthcare in 2009.

Alliance Healthcare

Walgreens Boots Alliance, Inc. engages in the provision of healthcare and retail pharmacy services. It operates through the following segments: United States Retail Pharmacy, International, and United States Healthcare. The US Retail Pharmacy segment includes the operation of retail drugstores, health and wellness services, specialty and home delivery pharmacy services, and equity method investment. The International segment offers pharmacy-led health and beauty retail businesses outside the US and the pharmaceutical wholesaling and distribution business in Germany. The US Healthcare segment delivers improved health outcomes and lower costs for payors and providers through owned and partnered assets. The company was founded by Charles R. Walgreen and John Boot in 1909 and is headquartered in Deerfield, IL.

Earnings data Q2 2021

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

Earnings data Q1 2025

Walgreens reports Q1 earnings decline, eyes growth opportunities ahead

Walgreens faces challenges from COVID impacts and investments but is on track to achieve full-year guidance.
Strategic acquisitions and scaling U.S. Healthcare present opportunities for growth and profitability.
Despite first-half declines, the company anticipates improvements in margins and performance in the second half.
Efforts to optimize cash flow and investments position Walgreens for future growth and success.

Walgreens reports 4.5% sales growth in Q2 2023 earnings

Walgreens remains cautiously optimistic about managing potential changes in health plans and anticipates a strong second half of the year. The company is targeting debt reduction and small tuck-on acquisitions in healthcare as capital allocation priorities.

Walgreens (WBA) reports mixed Q3 performance, focuses on profitability

Walgreens (WBA) Q3 2023 earnings call highlights mixed performance with a focus on profitability enhancement.
Strategic partnerships, cost management programs, and capital allocation priorities support long-term value creation.
Challenges in margin pressures, script growth, and operational issues require immediate actions for profitability.
Opportunities lie in unlocking profitability, market developments, and demand for risk-based health care services.

Walgreens appoints new CEO to drive cost savings and script growth opportunities

Walgreens is strategically positioning itself for operational efficiency and cost savings in fiscal year 2024. The company's new CEO, Tim Wentworth, is expected to drive healthcare expertise and cost-effective outcomes. Despite challenges like lower contributions and segment declines, Walgreens is leveraging opportunities for script growth and financial improvement.

Walgreens Q1 Earnings: Navigating Challenges, Focused on Value Creation

Walgreens is navigating challenges in the pharmacy sector while focusing on strategic initiatives to drive value creation and sustainable growth. The company's emphasis on partnerships, cost-saving actions, and a shift towards value-based reimbursement models positions them for future success in the evolving healthcare landscape.

Walgreens reports solid Q2 results, focuses on growth strategies

Walgreens navigates retail challenges with strong operational performance. Focus on cost discipline, portfolio optimization, and cash flow improvement. Strategic decisions to drive growth and unlock value in healthcare areas.

Walgreens Q3 Earnings Miss Expectations Amid Challenges

Walgreens' Q3 2024 earnings call highlighted a challenging quarter with missed expectations, driven by pressures in the retail pharmacy sector and adverse market conditions. CEO Tim Wentworth emphasized ongoing strategic reviews and cost management initiatives as key to navigating these challenges. The company remains committed to transforming its business model to better serve customers and improve operational efficiency.

Walgreens (WBA) reports Q4 earnings, focuses on growth strategies

Walgreens (WBA) focused on financial stability, cost efficiency, and strategic growth initiatives in Q4 2024 earnings call.
The company aims to address challenges like disruptions, inflation, and underperforming stores while leveraging strengths in cash flow and cost-cutting.
Opportunities in store optimization, digital enhancement, and asset monetization are key areas for future growth.
Overall, Walgreens is navigating challenges, leveraging strengths, and pursuing opportunities to enhance financial performance and resilience.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Boston Properties

Devon Energy

Invesco

KeyCorp

Kinder Morgan

Altria

Healthpeak Properties

Pioneer Natural Resources

AT&T

Truist Financial

Verizon

Whirlpool

There's nothing like a plunge in yields to 4.1% to cool the dash to buy 10-year Treasuries. Now you can buy S&P 500 stocks that yield more.

13 S&P 500 Dividend Stocks Pay 50% More Than 10-Year Treasuries

DEERFIELD, Ill.--(BUSINESS WIRE)--Walgreens is offering flu and COVID-19 testing appointments nationwide as the U.S. heads into the holidays and the winter months that typically coincide with peak respiratory illness season.1,2 Individuals can visit Walgreens.com/Testing, use the Walgreens app to schedule an appointment. Walgreens also provides various in-store and at-home testing and treatment options to help everyone stay healthy and feel better faster if they are experiencing symptoms. “Resp.

Walgreens Announces Expanded COVID-19 and Flu Testing and Treatment Offerings

CVS Health

Premier

Select Medical Holdings

Spok Holdings

UnitedHealth Group

U.S. Physical Therapy

With the equities sector falling flat while the cryptocurrency arena skyrockets, the difficulties associated with planning next moves help drive the bullish case for dividend-paying healthcare stocks. As a defensive play, the broader wellness ecosystem should instill confidence.

7 Dividend-Paying Healthcare Stocks for Income Investors

Over the past four years, investors have become very familiar with stock market volatility. Wild swings in the S&P 500 have been the norm as the index swung from bull to bear market and back again.

3 Dividend Stocks to Buy Before the Bear Market Starts

General Motors

Ford Motor Company

Hewlett Packard

Kraft Heinz

Mohawk Industries

Mosaic

Paramount Global

Tyson Foods

Viatris

Warner Bros Discovery Inc

It's no secret famed investor Warren Buffett sold off all his General Motor stock. But it's just one S&P 500 stock that worth more dead than alive.

11 Beat-Up Big Stocks (Like GM) Are Worth More Dead Than Alive

The Walgreens Boots Alliance stock price has been in decline since 2015. The current price of under $21 is almost the lowest level since 2008. Walgreens Boots Alliance still faces challenges such as higher labor costs, lower COVID-related demand, and leadership transition.

Walgreens: Outlook After CEO Tim Wentworth Took Office

Dow Inc

This huge drugstore chain is a safe retail play for investors looking to add health care now and trades at a very cheap 7.5 times 2023 earnings expectations.

Highest Yielding ‘Dogs of the Dow' Could Be Massive Total Return Winners For 2024

the recent WBA share price of $20.79 represents a price-to-book ratio of 0.9 and an annual dividend yield of 9.2%

This Dow Component Has A 9.2% Yield And Sells For Less Than Book

Walgreens Boots Alliance (WBA) reachead $20.79 at the closing of the latest trading day, reflecting no change compared to its last close.

Walgreens Boots Alliance (WBA) Flat As Market Sinks: What You Should Know

Amgen

Cisco Systems

Chevron

Goldman Sachs

Johnson & Johnson

Coca-Cola

Merck

Walmart

"The Dow [adds a stock] if the company has an excellent reputation, demonstrates sustained growth, and is of interest to a large number of investors. Sector representation is also a consideration.” – Dow Jones & Co. The highest-yield 10 stocks are December's Dogs of the Dow: KO, AMGN, CSCO, GS, IBM, CVX, DOW, MMM, VZ, and WBA. They only averaged a 4.92% annual yield, as December prices rose. Thirty Dow stocks represent nine of eleven sectors. Dow Jones tracks utilities as a separate index and omits real estate. Broker top-ten target-estimated December net gains ranged between 11.08%-44.04%, topped by WBA 11/30/23.

December Dogs Of The Dow: 3 Buyable, 5 Watchable

Air Products and Chemicals

High-yield Dividend Aristocrats have underperformed the market this year, with the SPDR S&P Dividend ETF down over 3%. Dividend growth strategies offer benefits such as compounding reinvested dividends and generating a high yield on cost. Companies like Walgreens and Air Products may have to slow their dividend growth or potentially cut their dividends due to weak cash flow performance.

2 Dividend Aristocrats To Avoid

Medical Properties Trust

High-dividend-yield stocks are often very risky, and they might not even pay out. Walgreens Boots Alliance is struggling to diversify during a financial crunch.

2 High-Yield Dividend Stocks That'll Probably Let You Down

Walgreens looks to be a big player in healthcare as it launches primary and virtual care services. However, the company is struggling with profitability and already spending a lot on its dividend.

Walgreens Boots Alliance Stock: Bear vs. Bull

Walgreens (WBA) introduces Rx Savings Finder to help patients save on prescription medications.

Walgreens (WBA) Launches Rx Savings Finder Digital Tool

Cigna

ConocoPhillips

Hess

Humana

Paycom Software

Exxon Mobil

Energy was the sole S&P 500 sector to decline this month as the index marched toward its best month since July 2022.

These Stocks Were Left Behind In November's Historic Rally

BOSTON--(BUSINESS WIRE)--RxSense®, the healthcare technology company delivering industry-leading solutions for pharmacy benefits and prescription savings, today announced its collaboration with Walgreens to launch a new digital marketplace for consumers to access lower prices on thousands of prescription medications at Walgreens pharmacies nationwide. Through the new Rx Savings Finder, Walgreens customers can now conveniently compare prices available through a variety of free prescription disco.

Walgreens Taps RxSense to Power “Rx Savings Finder”, a New Digital Marketplace for Prescription Discounts

Walgreens Boots Alliance's dividend yield has risen from 4% to nearly 10% in a span of just a couple of years. The company's lackluster results, including a lack of profitability, are key reasons why Walgreens' stock has crumbled this year.

Is a Dividend Cut Inevitable for Walgreens Boots Alliance Stock?

Walgreens Boots Alliance's dumpster fire turnaround effort continues to fail, with S&P being so surprised by its earnings miss that it downgraded it to BBB- negative outlook. Walgreens has a 33% chance of losing its investment grade credit rating, and S&P is starting to put pressure on it to cut the dividend. This means an 11% chance of Walgreens going to zero. The growth outlook has plunged to -5%.

Sell Walgreens And Buy These Amazing 9% Yielding Alternatives

DEERFIELD, Ill.--(BUSINESS WIRE)--Walgreens today announced the launch of its new Rx Savings Finder, a simple-to-use digital tool designed to help customers save money on prescription medications. Rx Savings Finder finds free, third-party discount cards, providing patients with a quick and easy way to find lower prices on their Walgreens medications. “Inflation not only impacts our pockets but can have serious implications on health,” said Rick Gates, chief pharmacy officer, Walgreens. “Over on.

Walgreens Launches Rx Savings Finder to Help Patients Save on Prescription Medications

Ares Capital

Banco de Chile

British American Tobacco

Ecopetrol

Companhia Paranaense de Energia - COPEL

Enterprise Products Partners

Energy Transfer LP Unit

MPLX

Petroleo Brasileiro

Stellantis N.V. 

Telefonica SA

Vodafone Group

Dogsofthedow.com, or DOD, recently published its list of 50 large-cap high-dividend stocks as of 11/27/23 per data from YCharts. The DOD list targeted-investors who “don't want to simply focus on a high dividend yield only to discover that the stock price has plunged or that the corporation went belly-up.”. Investors reduce volatility/risk by limiting high-dividend search to large-well-established companies.

50 Large-Cap High-Yield Stocks For December

News for Walgreens Stock (WBA)